Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer

Back

Shyam S. Mohapatra

Shyam S. Mohapatra

Professor and Associate Dean
University of South Florida
USA

Biography

Synopsis: Shyam S. Mohapatra, PhD, MBA, FNAI, FAIMBE, FAAS is a Distinguished USF Health Professor and Director of the Division of Translational Medicine at the University of South Florida Department of Internal Medicine. He also directs the USF Center for Research and Education in Nanobioengineering. He serves as a research career scientist at the James A. Haley VA Hospital in Tampa His research has brought USF over $30 million in extramural funds, and he has published over 200 papers and holds over 40 U.S. and foreign patents. He is recognized for his many inventions in the field of nanoscale biomedical diagnostics and therapeutics in cancers, asthma, viral infections, and traumatic brain injury. In cancers, his inventions and co-inventions have led to several technology platforms and products for innovative anti-cancer drug discovery, drug development, and personalized cancer treatment. His research has spawned inventions that have spun out companies. He co-founded Transgenex Nanobiotech Inc, a USF spin-out company that focuses on commercializing nanoscale innovations. He is a Charter Fellow of the National Academy of Inventors; a fellow of the American Academy of Allergy, Asthma & Immunology; American Association of Medical and Biological Engineers; and American Association of Advancement of Science; and is one of the inaugural (2014) inductees of the Florida Inventors Hall of Fame. Since 2014, he has served as Associate Dean of Graduate Programs at the USF College of Pharmacy and established a highly innovative Master of Science program in pharmaceutical nanotechnology with additional concentrations in Drug Discovery and Development and Biomedical engineering. This program has grown exponentially generating a revenue of ~$1Million in three years. He founded and has directed the VA colorectal cancer cell genomics consortium since 2017, which encompases linked (about 12 different VA Hospitals) research programs in colorectal cancers.

Research Interest

Nanobioengineering